Streetbeat News

Stock Prices

ECPG

Encore Capital shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 4:30 pm

ALDX

Aldeyra Therapeutics Inc. (NASDAQ: ALDX) announced that its Phase 3 clinical trial for the dry eye drug reproxalap met its primary endpoint, showing significant improvement in ocular discomfort. The study's success has led to a 34.8% increase in ALDX stock price. The company plans to resubmit its New Drug Application (NDA) to the FDA in 2024, with a review period expected to last six months.

Portfolio Pulse from Vandana Singh

August 08, 2024 | 4:30 pm

UONE

Urban One shares are trading higher following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 4:28 pm

AMPY

Amplify Energy shares are trading higher after the company reported better-than-expected sales results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 4:27 pm

DHX

DHI Group shares are trading higher following the company's announcement of better-than-expected Q2 adjusted EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 4:26 pm

BROS

Dutch Bros Inc. (NYSE:BROS) shares are falling after the company reported its second-quarter results. Despite beating analyst expectations on the top and bottom lines, the company issued full-year revenue guidance below the consensus estimate. Analysts have adjusted their price targets, with Baird lowering from $42 to $37 and TD Cowen from $50 to $47. The stock is down 20.6% at $29.92, trading well below its 50-day moving average of $38.98.

Portfolio Pulse from Erica Kollmann

August 08, 2024 | 4:25 pm

AAPL

AMZN

GOOG

META

MSFT

NVDA

QQQ

SPY

TBT

TLT

TSLA

The article discusses the impact of a weak Treasury auction and jobless claims on the stock market. It highlights the importance of monitoring the S&P 500 ETF (SPY) and Nasdaq 100 ETF (QQQ), as well as the Magnificent Seven stocks (AAPL, AMZN, GOOG, META, MSFT, NVDA, TSLA). The Bank of Japan's hawkish stance and the weak Treasury auction have led to market volatility. Investors are advised to consider protection bands and focus on high-quality bonds.

Portfolio Pulse from The Arora Report

August 08, 2024 | 4:25 pm

SNY

Sanofi SA (NASDAQ:SNY) reported positive results from the GMMG-HD7 phase 3 study of Sarclisa in combination with other drugs for treating multiple myeloma. The study showed significant improvement in progression-free survival. The FDA has accepted a supplemental Biologics License Application for Sarclisa, with a decision expected by September 27, 2024.

Portfolio Pulse from Vandana Singh

August 08, 2024 | 4:23 pm

FCG

FTXN

NETZ

OILT

OXY

RSPG

Occidental Petroleum (NYSE: OXY) exceeded Q2 earnings expectations but received a neutral outlook from analysts due to concerns over its balance sheet, slowing chemicals business, and asset sales strategy. Despite the earnings beat, analysts expect a neutral impact on the stock's near-term performance. ETFs tracking the stock also saw gains.

Portfolio Pulse from Michael Juliano

August 08, 2024 | 4:23 pm

KRMD

KORU Medical Systems shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 revenue guidance above estimates. Piper Sandler maintained an Overweight rating on the stock and raised its price target from $2.5 to $3.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 4:22 pm